In our upcoming issue of Nordic Life Science, Thomas Lönngren, former head of the EMA, emphasizes five important hurdles to identify for the pharmaceutical sector.
Thomas Lönngren’s years from the regulatory side and the last ten years as a consultant have provided him with a proper global ov